Amgen INC AMGEN ORD (CDI)/ US0311621009 /
1/23/2025 8:07:40 PM | Chg. - | Volume | Bid3:02:51 PM | Ask2:17:54 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
276.1700USD | - | 4,138 Turnover: 1.13 mill. |
263.5000Bid Size: 70 | 289.5000Ask Size: 70 | 149.37 bill.USD | 3.11% | 22.12 |
GlobeNewswire
8/29/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
8/28/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
8/15/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
8/12/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
8/8/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/8/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
8/5/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
8/1/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024